SSGA Active Trust has provided a detailed report on its State Street® My2030 Corporate Bond ETF in a recent SEC filing. This update is significant as it outlines the financial health and investment strategy of the fund, which is crucial for current and potential investors.
As of August 31, 2026, the fund reported total assets of approximately $52.38 million, with net assets standing at about $48.85 million. The filing indicates that the fund has no liabilities, showcasing a strong financial position. This information is particularly relevant for stakeholders in the investment management sector, as it reflects the fund's ability to manage assets effectively.
Background
SSGA Active Trust, classified under the investment category, is a prominent player in the financial services industry. The company operates under the Central Index Key (CIK) 0001516212 and has been active in filing various reports with the SEC. Its recent filings include multiple NPORT-P forms, showcasing its commitment to transparency and regulatory compliance.
What the Filing Says
The latest filing, accession number 0001410368-26-109155, highlights the fund's robust asset management. It states, "The fund had total assets of $52,376,011.15 and net assets of $48,851,208.81." This emphasizes the fund's stability and potential for future growth.
Impact
This filing may significantly impact investors and analysts monitoring the investment management sector. The detailed financial data provided can influence investment decisions and strategies, as stakeholders assess the fund's performance and stability in the current market landscape.
What's Next
The filing does not say what happens next, leaving stakeholders to anticipate further updates from SSGA Active Trust regarding their investment strategies and fund performance.
Read Next
van Houte Hans Reports Stock Transactions at Nurix Therapeutics
Hansen Gwenn Acquires and Sells Shares at Nurix Therapeutics
Drouillard Vincent Amends Filing to Correct Share Sale Details
Drouillard Vincent reports sale of 10,000 shares in AerCap
Gilead Sciences CEO Daniel O'Day Executes Multiple Stock Sales
Le Peuch Olivier Sells 25,000 Shares of SLB Limited





